Clinical trials to develop new treatment options for visceral leishmaniasis in east Africa.
Khartoum University
Institue of Endemic Diseases .
Prof. Ahmed Musa Mudawi
Prof. ElTahir , Dr. Brima .
4 weeks
Cities/Months Jan Feb Mar Apr May Jun Jul Augt Sep Oct Nov Dec
Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes Yes
Type of Research Project
- Clinical Project with Laboratory work
What is the background of the project?
Visceral leishmaniasis (VL) is a fatal parasitic disease with 500,000 new cases each year according to WHO estimates. New and better treatment options are urgently needed in disease endemic areas due to the long courses, toxicity and development of resistance to current treatments. Recently, the antibiotic paromomycin was tested and registered in India to treat this disease. The current study describes a clinical trial to test the effectiveness of injectable paromomycin, either alone or in combination with the standard drug sodium stibogluconate in three East African countries?Sudan, Kenya and Ethiopia.
What is the aim of the project?
What techniques and methods are used?
What is the role of the student?
What are the tasks expected to be accomplished by the student?
Will there be any theoretical teaching provided (preliminary readings, lectures, courses, seminars etc)
What is expected from the student at the end of the research exchange? What will be the general outcome of the student?
- the role of the student will be determined by the tutor himself and we expect our incoming to be as of interest as he can.
What skills are required of the student? Is there any special knowledge or a certain level of studies needed?
*Basic knowledge about Lieshmaniasis ( the Institue will offer materials to study during the project )
* a white labcoat.
Are there any legal limitations in the student’s involvement

Type of students accepted
This project accepts:
- Medical students
- Graduated students (less than 6 months)
- a:0:{}